Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

Caitlin E. Cox

October 31, 2024

Presentation TCT 2024

TCT 1373: Treatment of Critical Limb Ischemia in Severe Aortic Stenosis

Presenter: Zoltan Ruzsa

October 28, 2024

Presentation TCT 2024

TCT 394: Peripheral Bioresorbable Scaffold Made by Multi-Axial Extrusion Technology: New Material, Design and First-in-Human Experience

Presenter: Yuxian Luo

October 27, 2024

Presentation TCT 2024

TCT 397: Comparative Outcomes of Below-the-Knee CTO vs Non-CTO Peripheral Artery Interventions From the XLPAD Registr

Presenter: Minseob Jeong

October 27, 2024

Presentation TCT 2024

TCT 396: Outcomes of Below the Knee Chronic Total Occlusions Interventions: Insights From the XLPAD Registry

Presenter: Deepakraj Gajanana

October 27, 2024

Presentation TCT 2024

TCT 395: Differences in Outcomes Between Rutherford 4 and Rutherford 5/6 Patients Undergoing Endovascular Intervention for Lower Extremity Peripheral Artery Disease

Presenter: Daniel Snyder

October 27, 2024

Presentation TCT 2024

TCT 30: Comparative Outcomes of Non-Stent Below-the-Knee Peripheral Artery Interventions in Critical Limb Threatening Ischemia vs Intermittent Claudication From the XLPAD Registry

Presenter: Minseob Jeong

October 27, 2024

Presentation TCT 2024

TCT 26: Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: Data From the LIFE-BTK Pharmacokinetics Sub-Study

Presenter: Richard Pin

October 27, 2024

Presentation TCT 2024

TCT 29: The Changing Landscape of Treatment Setting for Chronic Limb Threatening Ischemia Among Medicare Beneficiaries

Presenter: Joseph Kim

October 27, 2024

Presentation TCT 2024

TCT 28: Target Vessel Revascularization and Amputation After Chronic Limb-Threatening Ischemia Across Race Among Medicare Beneficiaries

Presenter: Joseph Kim

October 27, 2024

Presentation TCT 2024

TCT 27: Pre-Clinical Data on a Novel Hybrid Drug-Eluting Stent With Nanocoating for Below-the-Knee Lesions: “Leave the Right Thing Behind”

Presenter: Emi Kearon

October 27, 2024

Presentation TCT 2024

TCT 25: Endovascular Intervention Versus Bypass Surgery in the Treatment of Chronic Limb-Threatening Ischemia: A Meta-Analysis of Randomized Control Trials

Presenter: Shadi Halabi

October 27, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Conference News ISET 2024

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

Caitlin E. Cox

January 24, 2024

Advertisement

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

TCT 1373: Treatment of Critical Limb Ischemia in Severe Aortic Stenosis

TCT 394: Peripheral Bioresorbable Scaffold Made by Multi-Axial Extrusion Technology: New Material, Design and First-in-Human Experience

TCT 397: Comparative Outcomes of Below-the-Knee CTO vs Non-CTO Peripheral Artery Interventions From the XLPAD Registr

TCT 396: Outcomes of Below the Knee Chronic Total Occlusions Interventions: Insights From the XLPAD Registry

TCT 395: Differences in Outcomes Between Rutherford 4 and Rutherford 5/6 Patients Undergoing Endovascular Intervention for Lower Extremity Peripheral Artery Disease

TCT 30: Comparative Outcomes of Non-Stent Below-the-Knee Peripheral Artery Interventions in Critical Limb Threatening Ischemia vs Intermittent Claudication From the XLPAD Registry

TCT 26: Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: Data From the LIFE-BTK Pharmacokinetics Sub-Study

TCT 29: The Changing Landscape of Treatment Setting for Chronic Limb Threatening Ischemia Among Medicare Beneficiaries

TCT 28: Target Vessel Revascularization and Amputation After Chronic Limb-Threatening Ischemia Across Race Among Medicare Beneficiaries

TCT 27: Pre-Clinical Data on a Novel Hybrid Drug-Eluting Stent With Nanocoating for Below-the-Knee Lesions: “Leave the Right Thing Behind”

TCT 25: Endovascular Intervention Versus Bypass Surgery in the Treatment of Chronic Limb-Threatening Ischemia: A Meta-Analysis of Randomized Control Trials

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content